Volume 26, Number 9—September 2020
Dispatch
Mycobacterial Testing Trends, United States, 2009–20151
Table 1
Variable |
No. (%) patients† | No. (%) patients tested for AFB | Tests for AFB/10,000 patients‡ | Pathogenic NTM cases/10,000 patients | |
---|---|---|---|---|---|
Total |
10,802,134 (100.0) |
48,563 (100.0) |
45.0 |
3.1 |
|
Sex | |||||
F | 5,599,841 (51.8) | 22,975 (47.3) | 41.0 | 3.0 | |
M |
4,545,803 (42.1) |
25,585 (52.7) |
56.3 |
3.6 |
|
Age, y | |||||
<65 | 9,041,231 (83.7) | 27,830 (57.3) | 30.8 | 1.9 | |
≥65 |
1,984,443 (18.4) |
20,670 (42.6) |
104.2 |
8.3 |
|
Sex and age, y | |||||
F, <65 | 4,638,813 (42.9) | 12,797 (26.4) | 27.9 | 1.6 | |
F, ≥65 | 1,089,079 (10.1) | 10,144 (20.9) | 94.6 | 8.8 | |
M, <65 | 3,817,761 (35.3) | 15,030 (30.9) | 39.8 | 2.5 | |
M, ≥65 |
816,161 (7.6) |
10,526 (21.7) |
131.0 |
8.6 |
|
Census region | |||||
Midwest | 2,112,964 (19.6) | 11,866 (24.4) | 56.2 | 4.7 | |
Northeast | 4,155,756 (38.5) | 16,203 (33.4) | 39.0 | 2.2 | |
South | 3,020,093 (28.0) | 14,823 (30.5) | 49.1 | 3.1 | |
West |
1,513,321 (14.0) |
5,671 (11.7) |
37.5 |
3.2 |
|
Race§ | |||||
African American | 1,645,676 (15.2) | 8,639 (17.8) | 52.5 | 3.4 | |
Asian | 306,103 (2.8) | 1,458 (3.0) | 47.6 | 5.6 | |
White |
6,411,413 (59.4) |
34,300 (70.6) |
53.5 |
3.6 |
|
Concurrent conditions | |||||
Lung cancer | 56,719 (0.5) | 3,729 (7.7) | 657.5 | 24.9 | |
Rheumatoid arthritis | 52,004 (0.5) | 711 (1.5) | 136.7 | 6.7 | |
Cystic fibrosis | 3,835 (0.04) | 865 (1.8) | 2,255.5 | 276.4 | |
Chronic obstructive pulmonary disease | 165,107 (1.5) | 4,301 (8.9) | 260.5 | 19.9 | |
Bronchiectasis |
8,666 (0.1) |
1,588 (3.3) |
1,832.4 |
339.3 |
|
Teaching status indicator¶ | |||||
Nonteaching | 2,094,368 (19.4) | 7,815 (16.1) | 37.3 | 3.3 | |
Teaching |
8,816,749 (81.6) | 39,592 (81.5) | 44.9 | 3.0 |
*AFB, acid-fast bacilli; NTM, nontuberculous mycobacteria.
†Stratified totals do not always add up to 100% because of missing data and patients’ membership in multiple categories.
‡Patients with multiple tests or positive isolates are counted a single time.
§Racial/ethnic groups with small sample sizes and patients categorized as “Unknown” are not shown in stratified analysis.
¶Teaching status indicator refers to whether a facility visited by a patient is a teaching facility.
1Preliminary results from this study were presented at the IDWeek Conference; October 2–6, 2019; Washington, DC, USA.
2Current affiliation: Kaiser Permanente, Oakland, California, USA.
Page created: June 15, 2020
Page updated: August 19, 2020
Page reviewed: August 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.